Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125716061 | 12571606 | 1 | I | 20160705 | 20160719 | 20160719 | EXP | CA-HQ SPECIALTY-CA-2016INT000552 | INTERCHEM | 57.00 | YR | F | Y | 0.00000 | 20160719 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125716061 | 12571606 | 1 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Oral | 1.4286 MG (10 MG,1 IN 1 W) | 201749 | 10 | MG | ||||||||
| 125716061 | 12571606 | 2 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | UNK | 0 | |||||||||||
| 125716061 | 12571606 | 3 | SS | ARAVA | LEFLUNOMIDE | 1 | Oral | 20 MG (20 MG,1 IN 1 D) | 0 | 20 | MG | ||||||||
| 125716061 | 12571606 | 4 | SS | PLAQUENIL /00072602/ | HYDROXYCHLOROQUINE DIPHOSPHATE | 1 | Oral | UNK | 0 | ||||||||||
| 125716061 | 12571606 | 5 | SS | REMICADE | INFLIXIMAB | 1 | 3 MG/KG, UNK | 0 | 3 | MG/KG | |||||||||
| 125716061 | 12571606 | 6 | SS | RITUXAN | RITUXIMAB | 1 | 1000 MG, UNK | 0 | 1000 | MG | INFUSION | ||||||||
| 125716061 | 12571606 | 7 | SS | ACTEMRA | TOCILIZUMAB | 1 | 8 MG/KG, UNK | 0 | 8 | MG/KG | |||||||||
| 125716061 | 12571606 | 8 | C | ASCORBIC ACID. | ASCORBIC ACID | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125716061 | 12571606 | 1 | Rheumatoid arthritis |
| 125716061 | 12571606 | 2 | Rheumatoid arthritis |
| 125716061 | 12571606 | 3 | Rheumatoid arthritis |
| 125716061 | 12571606 | 4 | Rheumatoid arthritis |
| 125716061 | 12571606 | 5 | Rheumatoid arthritis |
| 125716061 | 12571606 | 6 | Rheumatoid arthritis |
| 125716061 | 12571606 | 7 | Product used for unknown indication |
| 125716061 | 12571606 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125716061 | 12571606 | HO |
| 125716061 | 12571606 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125716061 | 12571606 | Abdominal discomfort | |
| 125716061 | 12571606 | Drug ineffective | |
| 125716061 | 12571606 | Haematemesis | |
| 125716061 | 12571606 | Jaundice | |
| 125716061 | 12571606 | Nausea | |
| 125716061 | 12571606 | Rheumatoid arthritis | |
| 125716061 | 12571606 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125716061 | 12571606 | 1 | 20080916 | 20091022 | 0 | |
| 125716061 | 12571606 | 3 | 20080916 | 20091022 | 0 | |
| 125716061 | 12571606 | 5 | 20090625 | 20091022 | 0 | |
| 125716061 | 12571606 | 6 | 2012 | 2015 | 0 | |
| 125716061 | 12571606 | 7 | 20111026 | 2012 | 0 |